Quantitative Assessment of Myeloid Nuclear Differentiation Antigen Distinguishes Myelodysplastic Syndrome From Normal Bone Marrow
Sara A. McClintock-Treep(Vanderbilt University), David R. Head(University of Southern California), Andrew A. Shinar(Vanderbilt University Medical Center), Leanne A. Flye(Center for Innovation), Madan Jagasia(Vanderbilt University Medical Center), William D. Dupont(Vanderbilt University Medical Center), Robert C. Briggs(Vanderbilt University), Claudio A. Mosse(Breast Cancer Research Foundation), Keith Shults(Center for Innovation), Greg Stelzer(Center for Innovation)
Cited by 12
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
|New England Journal of Medicine|1985|1.9k
Age and acute myeloid leukemia
|Blood|2006|1.4k